CHARM IN-VESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND REDUCED LEFT-VENTRICULAR SYSTOLIC FUNCTION TAKING ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS: THE CHARM-ADDED TRIAL
Abstract
No abstract available for this paper.
Citation impact
1,045
total citations
- FWCI
- 55.12
- Percentile
- 100%
- References
- 0
Citations per year
Authors
9Topics & keywords
Keywords
- Candesartan
- Charm (quantum number)
- Heart failure
- Cardiology
- Internal medicine
- Medicine
- Ventricular function
- Angiotensin II
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.